AI
Wednesday, January 26, 2022 5:02:23 PM
So auph has a negative growth rate of 53%, sounds good to me…
Five analysts have issued estimates for Aurinia Pharmaceuticals’ earnings. The highest sales estimate is $26.70 million and the lowest is $20.29 million. Aurinia Pharmaceuticals posted sales of $50.03 million in the same quarter last year, which would indicate a negative year-over-year growth rate of 53.6%. The firm is scheduled to announce its next earnings results on Wednesday, February 23rd.
Five analysts have issued estimates for Aurinia Pharmaceuticals’ earnings. The highest sales estimate is $26.70 million and the lowest is $20.29 million. Aurinia Pharmaceuticals posted sales of $50.03 million in the same quarter last year, which would indicate a negative year-over-year growth rate of 53.6%. The firm is scheduled to announce its next earnings results on Wednesday, February 23rd.
